Cell-surface marker discovery for lung cancer

Lung cancer is the leading cause of cancer deaths in the United States. Novel lung cancer targeted therapeutic and molecular imaging agents are needed to improve outcomes and enable personalized care. Since these agents typically cannot cross the plasma membrane while carrying cytotoxic payload or i...

Descripción completa

Detalles Bibliográficos
Autores principales: Cohen, Allison S., Khalil, Farah K., Welsh, Eric A., Schabath, Matthew B., Enkemann, Steven A., Davis, Andrea, Zhou, Jun-Min, Boulware, David C., Kim, Jongphil, Haura, Eric B., Morse, David L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5768334/
https://www.ncbi.nlm.nih.gov/pubmed/29371917
http://dx.doi.org/10.18632/oncotarget.23009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5768334/
https://www.ncbi.nlm.nih.gov/pubmed/29371917
http://dx.doi.org/10.18632/oncotarget.23009

Ejemplares similares